| Submission declined on 9 July 2024 by
SafariScribe (
talk). This submission is not adequately supported by
reliable sources. Reliable sources are required so that information can be
verified. If you need help with referencing, please see
Referencing for beginners and
Citing sources. This submission's references do not show that the subject
qualifies for a Wikipedia article—that is, they do not show significant coverage (not just passing mentions) about the subject in published,
reliable,
secondary sources that are
independent of the subject (see the
guidelines on the notability of people). Before any resubmission, additional references meeting these criteria should be added (see
technical help and learn about
mistakes to avoid when addressing this issue). If no additional references exist, the subject is not suitable for Wikipedia.
Where to get help
How to improve a draft
You can also browse Wikipedia:Featured articles and Wikipedia:Good articles to find examples of Wikipedia's best writing on topics similar to your proposed article. Improving your odds of a speedy review To improve your odds of a faster review, tag your draft with relevant WikiProject tags using the button below. This will let reviewers know a new draft has been submitted in their area of interest. For instance, if you wrote about a female astronomer, you would want to add the Biography, Astronomy, and Women scientists tags. Editor resources
|  |
| Submission declined on 9 July 2024 by
SafariScribe (
talk). This submission is not adequately supported by
reliable sources. Reliable sources are required so that information can be
verified. If you need help with referencing, please see
Referencing for beginners and
Citing sources. Declined by
SafariScribe 25 hours ago. | |
Moe Alsumidaie
Mohammed "Moe" Alsumidaie (born October 22, 1983) is a journalist and expert in the clinical trials industry. He is known for his significant contributions to improving clinical trial efficiency, design, and management through innovative methodologies and technologies. Moe's in-depth articles and editorials, widely published in platforms like Applied Clinical Trials. [1], have made a profound impact on the clinical research community. He holds positions in several organizations dedicated to advancing clinical research and healthcare innovation.
Early Life and Education
Moe was born on October 22, 1983, in Cardiff, Wales. His father, Dr. Ayad Alsumidaie, was an oncology surgeon who studied in Alexandria, Egypt, and earned a Ph.D. at King's College, where he met his mother, Joumana Darwish Alsumidaie, who pursued a master's degree in education at King's College.
Moe's family moved to Baghdad in 1986 and later relocated to Beirut in 1990 to escape the Gulf War. In Beirut, Moe attended Eastwood International School in Beirut. In 1995, the family immigrated to Sunnyvale, California, where Moe completed his middle school and high school education at Cuptertino Middle School and at Homestead High School.
Moe holds a Bachelor of Science in Physiology and Neuroscience from the Earl Warren College at The University of California, San Diego. He also earned an MBA in Finance and Marketing, as well as a Master of Science in Finance (MSF) in Investment Finance & Technical Analysis from the D'Amore-McKim School of Business at Northeastern University.
Career
Early Career
Alsumidaie began his career in clinical research at Stanford University Medical Center, working on Phase II-IV studies, including cardiovascular and diabetes drugs, and medical devices. He then managed Phase IV cardiovascular clinical trials at Abbott Cardiovascular Devices. At Genentech, he optimized clinical operations for Phase III trials, achieving significant productivity and cost savings. Moe later oversaw 14 Phase I-IV clinical trials at Roche, leveraging outsourcing models and developing novel procedures for quality control and cost prediction. Finally, he served as Clinical Operations and Funding Advisor at Mount Sinai Health System, supporting echoinformatics and neuromodulation research.
Business Career
Moe Alsumidaie set off to start his business career in 2011 when he founded Annex Clinical Corporation, where he serves as Chief Data Scientist, developing solutions to improve clinical trial data management and integration. In 2015, Moe partnered with Krishma Shah when she graduated from Columbia University, to found CliniBiz, a collaboration highlighted in Forbes India [2] [3], making clinical trials more accessible and efficient to patients. Additionally, Moe has contributed to the field as an Editorial Advisory Board Member and Contributing Columnist for Applied Clinical Trials Magazine from October 2011 to April 2023, and as a Guest Lecturer at Rutgers University from May 2017 to February 2018, where he taught risk management and innovative technologies in clinical trial project management. Since August 2023, Moe is the Chief Editor of The Clinical Trial Vanguard, providing professionals with accurate news and insights on clinical trials.
Achievements
Impactful Publications
Alsumidaie contributed to significant discussions in medical research through articles in peer-reviewed journals such as the Journal of the American College of Cardiology [4] and The American Journal of Managed Care [5].
Legal Contributions
Alsumidaie's publications were referenced in an amicus brief for the US Supreme Court, supporting arguments that impact the legal landscape of clinical research [6]
Support for Clinical Trials in Communities
Advocated for the use of local drugstores for clinical trials, increasing accessibility for participants and enhancing public health initiatives [7]
References
- ^ "Applied Clinical Trials Online". Applied Clinical Trials. Retrieved 2024-07-09.
- ^ https://www.forbesindia.com/video/30-under-30-2022/better-participation-leads-to-better-medicine-krishma-shahforbes-india-30-under-30-2022/73813
- ^ https://www.forbesindia.com/article/30-under-30-2022/krishma-shah-making-clinical-trials-more-efficient/73759/1
- ^ Ashraf, Muhammad; Tokodi, Marton; Ali, Hama Amin; Virmani, Chetan; Alsumidaie, Moe; Hu, Lan; Sokos, George; Sengupta, Partho P. (March 2018). "NON-INVASIVE ASSESSMENT OF ACUTE DYSPNEA USING LUNG DOPPLER SIGNALS". Journal of the American College of Cardiology. 71 (11): A966. doi: 10.1016/S0735-1097(18)31507-9.
- ^ Ross G. Hewitt, M. D.; Debra Williams, EdD; Adule, Richard; Ira Feldman, M. P. S.; Moe Alsumidaie, M. B. A. (2019-06-04). "Enhanced Care Coordination Improves HIV Viral Load Suppression Rates". AJMC. June 2019. 25.
- ^ "Amicus Brief for 11 Professors in Support of Amgen Inc., et al. Amgen Inc. v. Sandoz Inc., No. 15-1195, Supreme Court of the United States. Available at: SCOTUS Blog" (PDF). June 12, 2017.
- ^ "Clinical Trials Are Now at Your Local Drugstore. What That Means for You". CNET. Retrieved 2024-07-09.
| Submission declined on 9 July 2024 by
SafariScribe (
talk). This submission is not adequately supported by
reliable sources. Reliable sources are required so that information can be
verified. If you need help with referencing, please see
Referencing for beginners and
Citing sources. This submission's references do not show that the subject
qualifies for a Wikipedia article—that is, they do not show significant coverage (not just passing mentions) about the subject in published,
reliable,
secondary sources that are
independent of the subject (see the
guidelines on the notability of people). Before any resubmission, additional references meeting these criteria should be added (see
technical help and learn about
mistakes to avoid when addressing this issue). If no additional references exist, the subject is not suitable for Wikipedia.
Where to get help
How to improve a draft
You can also browse Wikipedia:Featured articles and Wikipedia:Good articles to find examples of Wikipedia's best writing on topics similar to your proposed article. Improving your odds of a speedy review To improve your odds of a faster review, tag your draft with relevant WikiProject tags using the button below. This will let reviewers know a new draft has been submitted in their area of interest. For instance, if you wrote about a female astronomer, you would want to add the Biography, Astronomy, and Women scientists tags. Editor resources
| |
| Submission declined on 9 July 2024 by
SafariScribe (
talk). This submission is not adequately supported by
reliable sources. Reliable sources are required so that information can be
verified. If you need help with referencing, please see
Referencing for beginners and
Citing sources. Declined by
SafariScribe 25 hours ago. | |
Moe Alsumidaie
Mohammed "Moe" Alsumidaie (born October 22, 1983) is a journalist and expert in the clinical trials industry. He is known for his significant contributions to improving clinical trial efficiency, design, and management through innovative methodologies and technologies. Moe's in-depth articles and editorials, widely published in platforms like Applied Clinical Trials. [1], have made a profound impact on the clinical research community. He holds positions in several organizations dedicated to advancing clinical research and healthcare innovation.
Early Life and Education
Moe was born on October 22, 1983, in Cardiff, Wales. His father, Dr. Ayad Alsumidaie, was an oncology surgeon who studied in Alexandria, Egypt, and earned a Ph.D. at King's College, where he met his mother, Joumana Darwish Alsumidaie, who pursued a master's degree in education at King's College.
Moe's family moved to Baghdad in 1986 and later relocated to Beirut in 1990 to escape the Gulf War. In Beirut, Moe attended Eastwood International School in Beirut. In 1995, the family immigrated to Sunnyvale, California, where Moe completed his middle school and high school education at Cuptertino Middle School and at Homestead High School.
Moe holds a Bachelor of Science in Physiology and Neuroscience from the Earl Warren College at The University of California, San Diego. He also earned an MBA in Finance and Marketing, as well as a Master of Science in Finance (MSF) in Investment Finance & Technical Analysis from the D'Amore-McKim School of Business at Northeastern University.
Career
Early Career
Alsumidaie began his career in clinical research at Stanford University Medical Center, working on Phase II-IV studies, including cardiovascular and diabetes drugs, and medical devices. He then managed Phase IV cardiovascular clinical trials at Abbott Cardiovascular Devices. At Genentech, he optimized clinical operations for Phase III trials, achieving significant productivity and cost savings. Moe later oversaw 14 Phase I-IV clinical trials at Roche, leveraging outsourcing models and developing novel procedures for quality control and cost prediction. Finally, he served as Clinical Operations and Funding Advisor at Mount Sinai Health System, supporting echoinformatics and neuromodulation research.
Business Career
Moe Alsumidaie set off to start his business career in 2011 when he founded Annex Clinical Corporation, where he serves as Chief Data Scientist, developing solutions to improve clinical trial data management and integration. In 2015, Moe partnered with Krishma Shah when she graduated from Columbia University, to found CliniBiz, a collaboration highlighted in Forbes India [2] [3], making clinical trials more accessible and efficient to patients. Additionally, Moe has contributed to the field as an Editorial Advisory Board Member and Contributing Columnist for Applied Clinical Trials Magazine from October 2011 to April 2023, and as a Guest Lecturer at Rutgers University from May 2017 to February 2018, where he taught risk management and innovative technologies in clinical trial project management. Since August 2023, Moe is the Chief Editor of The Clinical Trial Vanguard, providing professionals with accurate news and insights on clinical trials.
Achievements
Impactful Publications
Alsumidaie contributed to significant discussions in medical research through articles in peer-reviewed journals such as the Journal of the American College of Cardiology [4] and The American Journal of Managed Care [5].
Legal Contributions
Alsumidaie's publications were referenced in an amicus brief for the US Supreme Court, supporting arguments that impact the legal landscape of clinical research [6]
Support for Clinical Trials in Communities
Advocated for the use of local drugstores for clinical trials, increasing accessibility for participants and enhancing public health initiatives [7]
References
- ^ "Applied Clinical Trials Online". Applied Clinical Trials. Retrieved 2024-07-09.
- ^ https://www.forbesindia.com/video/30-under-30-2022/better-participation-leads-to-better-medicine-krishma-shahforbes-india-30-under-30-2022/73813
- ^ https://www.forbesindia.com/article/30-under-30-2022/krishma-shah-making-clinical-trials-more-efficient/73759/1
- ^ Ashraf, Muhammad; Tokodi, Marton; Ali, Hama Amin; Virmani, Chetan; Alsumidaie, Moe; Hu, Lan; Sokos, George; Sengupta, Partho P. (March 2018). "NON-INVASIVE ASSESSMENT OF ACUTE DYSPNEA USING LUNG DOPPLER SIGNALS". Journal of the American College of Cardiology. 71 (11): A966. doi: 10.1016/S0735-1097(18)31507-9.
- ^ Ross G. Hewitt, M. D.; Debra Williams, EdD; Adule, Richard; Ira Feldman, M. P. S.; Moe Alsumidaie, M. B. A. (2019-06-04). "Enhanced Care Coordination Improves HIV Viral Load Suppression Rates". AJMC. June 2019. 25.
- ^ "Amicus Brief for 11 Professors in Support of Amgen Inc., et al. Amgen Inc. v. Sandoz Inc., No. 15-1195, Supreme Court of the United States. Available at: SCOTUS Blog" (PDF). June 12, 2017.
- ^ "Clinical Trials Are Now at Your Local Drugstore. What That Means for You". CNET. Retrieved 2024-07-09.